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Transcriptomics of the endometrium in mares susceptible and resistant to 
persistent breeding-induced endometritis using RNA-Sequencing 
 
Abstract 
This study aimed to investigate the susceptibility of mares to persistent breeding 
induced endometritis (PBIE) and fertility by transcriptomic analysis of uterine 
samples using RNA-Sequencing. Cytobrush samples were collected from the 
uterus of 81 broodmares before artificial insemination (AI). Susceptibility to PBIE 
was evaluated by the amount of intrauterine fluid 24 hours after AI and fertility 
was determined by a sonographic pregnancy diagnosis two weeks after ovulation. 
RNA expression profiles were compared between susceptible non- pregnant 
(SNP) mares (n=16) and resistant pregnant (RP) mares (n=21) as well as between 
susceptible pregnant (SP) mares (n=9) and susceptible non-pregnant (SNP) mares 
(n=16). Sixty-six genes were differentially expressed (DEGs) between SNP- and 
RP mares and 60 DEGs were noticed between SP- and SNP mares. In SNP 
compared to RP mares, gene expressions regulating steroid hormone metabolism 
and chemotaxis of neutrophils were lower, while those participating in uterine 
inflammation were higher. DEGs related to extracellular matrix degradation, 
tissue adhesions and fibrosis were lower in SP mares than in SNP mares, while 
gene expressions, which are related to uterine cell proliferation, differentiation, 
and angiogenesis were higher in SP mares than in SNP mares. In conclusion, there 
were substantial differences in the uterine transcriptome profiles according to 
susceptibility to persistent breeding induced endometritis and fertility in mares. 






In dieser Studie wurde die Anfälligkeit von Stuten für eine persistierende, 
besamungsinduzierte Endometritis (PBIE) und die Fertilität anhand der 
Transkriptomanalyse uteriner Proben mittels RNA-Sequenzierung (RNA-Seq) 
untersucht. Dazu wurden von 81 Stuten vor der künstlichen Befruchtung (KB) Zytobrush-
Proben vom Uterus entnommen und eine PBIE anhand der Menge intrauteriner 
Flüssigkeit 24 Stunden nach der KB sowie die Fertilität 2 Wochen später mittels 
Ultraschall diagnostiziert. Die RNA-Expressionsprofile wurden zwischen anfälligen 
nicht-trächtigen (ANT; n = 16) und resistenten trächtigen Stuten (RT; n = 21) sowie 
zwischen AT (n = 9) und ANT (n = 9) verglichen. Zwischen ANT und RT waren 66 Gene 
unterschiedlich exprimiert und zwischen AT und ANT 60 Gene. Bei ANT waren im 
Vergleich zu RT die Expressionen von Genen, die den Steroidhormonstoffwechsel und die 
Chemotaxis von Neutrophilen regulieren, geringer, und von Genen, die an einer 
Uterusentzündung beteiligt sind, höher exprimiert. Gene, die mit dem Abbau der 
extrazellulären Matrix, Gewebeadhäsionen und Fibrosierungen zusammenhängen, waren 
bei AT niedriger als bei ANT exprimiert, während Gene, die mit der Proliferation und 
Differenzierung uteriner Zellen und der Angiogenese zusammenhängen, bei AT höher 
waren exprimiert waren als bei ANT. Zusammenfassend unterschieden sich die 
Transkriptom-Profile in Abhängigkeit von der Anfälligkeit gegenüber einer besamungs-
induzierten Endometritis und der Fertilität der Stuten. 
 
SCHLÜSSELWÖRTER: Pferd, persistierende besamungsinduzierte Endometritis, 











        Abbreviations 
 
 
ADAMTS A disintegrin and metalloprotease with a thrombospondin motif 
ADAMTS6 ADAM metallopeptidase with thrombospondin type 1 motif 6 
AI Artificial insemination 
APOE Apolipoprotein E 
BIE Breeding induced endometritis 
CD44 Cluster domain 44 
cm Centimeter 
COL4A3 Collagen type IV alpha 3 chains 
COL5A2 Collagen type V alpha 2 chains 
CPM Counts per million 
CXCL C-X-C motif chemokine ligand 
CXCR C-X-C chemokine receptor 
DEGs Differentially expressed genes 
E2 Estrogen 
EBD1 Equine ꞵ-defensin 1 
ECM Extracellular matrix 
EGF Epidermal growth factor 
EGFR Epidermal growth factor receptor 
FBN1 Fibrillin 1 
FDR False discovery rate 
FGF9 Fibroblast growth factor 9 
FGFR Fibroblast growth factor receptor 
FN1 Fibronectin 




h Hour/ Hours 
HA Hyaluronic acid 
HB-EGF Heparin-binding EGF-like growth factor 
HPF High power field 
IL 1 Interleukin 1 
IL 17 Interleukin 17 
IL 6 Interleukin 6 
IL23A Interleukin-23 subunit alpha 
ITGB3 Integrin beta 3 
KDR kinase insert domain receptor 
LDLR low-density lipoprotein receptor 
LPS Lipopolysaccharide 
LYZ Lysozyme 
MMPs Matrix metalloproteinases 
mRNA Messenger RNA 
NCBI National center for biotechnology information 
NF-κB Nuclear factor kappa-light-chain-enhancer of activated B 
cells 
NOS-2 Nitric oxide synthase 2 
OPN Osteopontin 
P4 Progesterone 
PBIE Persistent breeding induced endometritis 
PMNs Polymorphonuclear neutrophils 
RIN RNA integrity numbers 







RNF175 Ring finger protein 175 
RNP Resistant non pregnant 
ROBO 2 Roundabout 2 
RP Resistant pregnant 
SLPI Secretory leukoprotease inhibitor 
SNP Susceptible non-pregnant 
SP Susceptible pregnant 
TGF-α Transforming growth factor-alpha 
TGF-ꞵ Transforming growth factor-beta 
Th17 T helper 17 
TNF-alpha Tumor necrosis factor-alpha 
VEGF Vascular endothelial growth factor 
VEGFR2 Vascular endothelial growth factor receptor 2 












         1. Introduction 
Endometritis has been ranked as the most important reason for subfertility in 
mares and the third most frequent disease of adult horses, reflecting a substantial 
economic and genetic loss in the equine breeding sector (Traub-Dargatz et al. 
1991, Gutjahr et al. 2000). LeBlanc (2010) categorized the inflammation of the 
endometrium into acute/ chronic infectious, persistent breeding induced (PBIE), 
and degenerative endometritis. Most common are bacterial infections and PBIE 
(Christoffersen and Troedsson 2017). 
Transient breeding-induced endometritis (BIE) is a local, physiological 
inflammatory reaction of the equine uterus that begins shortly after breeding to 
eliminate invasive microorganisms and excessive seminal components 
(Troedsson 1999). While a timely regulated inflammatory response is desirable to 
establish a healthy uterine environment before embryo descent, the persistence of 
this condition (PBIE) may develop an embryotoxic uterine environment in 
addition to triggering a premature luteolysis, which subsequently threatens the 
maintenance of pregnancy (Causey 2006, Woodward and Troedsson 2013a). 
Mares are classified as resistant or susceptible to PBIE based on their ability to clear 
uterine inflammation and fluids in a timely post-breeding manner. Many mares 
(85-90 %) are reproductively healthy and can efficiently control BIE within 24 
hours of breeding, while a minority (10-15 %) is unable to regulate this 
inflammatory reaction on time, so they are considered susceptible to PBIE 
(Troedsson, 1999, Christoffersen and Troedsson, 2017). 
PBIE has a multi-factorial nature that makes its diagnosis challenging. The 
prediction of susceptibility is usually limited to the history of subfertility/ 
abnormal intrauterine fluid accumulation or the presence of score IIB-III 
endometrium according to the histological classification of Kenney and Doig, so 
being able to detect the susceptible mares in advance is critical to provide them 
with a special breeding management to increase pregnancy rates (Kenney and 
Doig 1986, Troedsson et al. 1993, Maischberger 2008, Rasmussen et al. 2015). 
Although swab, cytobrush, low-volume lavage, and biopsy are used to gather 
uterine samples for the classical diagnosis (microbiology, cytology, and histology) 
of endometritis in mares (Ferris 2016), the histological evaluation of uterine 
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biopsy samples has been considered to be the most specific and sensitive 
diagnostic method for endometritis particularly for deep chronic uterine infections 
(De Amorim et al. 2015). 
Since a few years, the uterine biopsy is not only used for histological assessment 
but also for investigation of the expression of some genes in the equine uterus. 
Recently, the RNA-Seq technique has been used to provide a broad range of 
transcriptomic data that helps to understand genetic changes and biological 
dynamics associated with physiological and pathological processes in different 
tissues of organs (Metzker 2010, Ozsolak and Milos 2011). The uterine RNA-Seq 
allows a better understanding of the pathophysiology of endometritis and provides 
additional, more objective information about the susceptibility to PBIE compared 
to subjective histological evaluations (Woodward and Troedsson, 2015, 
Christoffersen and Troedsson, 2017). 
Cytobrush can collect cells of high integrity from both the surficial and deep layers 
of the uterus that may be used for microbiological, cytological as well as 
transcriptomic assessments (Cocchia et al. 2012, Ferris et al. 2016, Palma-Vera et 
al. 2015). Equine breeders and practitioners prefer using the cytobrush to diagnose 
endometritis rather than biopsy under field conditions as cytobrush is considered 
an effective, practical and non-invasive technique (Overbeck et al. 2011, 
Buczkowska et al. 2014). RNA-Seq of the uterus in equine and human medicine 
was up to now performed on biopsy samples (Woodward and Troedsson, 2015), 
while in cows and recently in mares it was shown that cytobrush samples can 
provide an adequate quantity and quality of RNA isolates for transcriptomic 
analysis ( Minten et al. 2013, Wagener et al. 2017, Weber et al 2020). Cytobrush 
samples have been reported to show higher levels of gene expression than biopsy 
samples in cows with endometritis (Fagundes et al. 2019). 
However, previous studies were focusing on the retrospective diagnosis of PBIE 
by investigating some genes in biopsy samples after challenging the uterus by 
insemination or inoculation of bacteria (Woodward and Troedsson, 2015), only 
one study has tried to investigate the susceptibility of mares to develop a PBIE by 
examining the association between the endometrial histology score and 
intrauterine fluid accumulation post-breeding (Woodward et al. 2012). 
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 Recently, Marth et al. (2018) suggested that equine ꞵ-defensin 1 (EBD1), lysozyme 
(LYZ), and secretory leukoprotease inhibitor (SLPI) could be used as diagnostic 
markers to identify PBIE-susceptible mares with 94% overall sensitivities and 
specificities. In the last- mentioned study, the uterine biopsy samples were 
collected in estrus and diestrus for transcriptomic analysis of selected immune 
genes from mares that were retrospectively categorized as susceptible or resistant 
to PBIE during previous estrous cycles, the authors did not correlate their findings 
of uterine gene expression with the intrauterine fluid accumulation post-breeding 
or fertility results. 
We hypothesized that mares susceptible and resistant to PBIE may have different 
uterine RNA profiles even before they are challenged by breeding. Furthermore, 
the uterine RNA profiles before breeding may affect the fertility of the mares 
which may reveal some molecular biomarkers for the susceptibility to PBIE as 
well as mare fertility. Our study aimed to examine the whole transcriptome 
profiles of uterine cytobrush samples collected before breeding from an 
uncategorized broodmare population and subsequently to compare the mRNA 
expression levels based on the post-breeding uterine reaction and the result of the 
pregnancy diagnosis in order to investigate 1) the susceptibility to PBIE by 
comparing the uterine transcriptome profiles in susceptible mares that did not 
become pregnant in comparison to resistant mares that became pregnant, as well 
as to investigate 2) the ability of susceptible mares to become pregnant with the 
proper breeding management by comparing the uterine transcriptome profiles of 
susceptible that became pregnant and susceptible mares that did not. 
 
        2. Materials and Methods 
           2.1 Mares 
The current study was performed from May to August 2019 on Standardbred 
mares at a large private equine stud farm in Mecklenburg-Vorpommern, Germany. 
Mares were light horses (400-550 kg) kept on straw-bedded boxes with permanent 
access to hay, grain, and water, and were turned out daily to pasture. We selected 
mares that were ≥10 years of age with no history of reproductive disorders or 
clinical symptoms of endometritis during previous estrous cycles and were 
planned to be artificially inseminated (AI) with cooled semen from an already 
proven fertile stallions (certified for the commercial breeding purpose) 
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          2.2 Study design 
The schedule for reproductive management and sampling of the mares is shown in 
Fig. 1. After a routinely performed transrectal palpation and ultrasonography of 
the genital tract to evaluate their ovarian and uterine status, uterine cytobrush 
samples were collected before AI from 81 mares during estrus. Afterwards, 
ovulation was hormonally induced. Twenty-four hours later mares were 
inseminated with cooled semen and further 24 hours mares were examined for the 
onset of ovulation (mares which did not ovulate within 48 hours of induction were 
excluded from the study). As 9 mares did not ovulate within 48 hours after 
induction of ovulation, the remaining 72 mares were grouped based on their 
maximum diameter of intrauterine fluid. Mares showing intrauterine fluid  2cm 
in diameter 24 hours after AI were defined as susceptible mares (n=25) while 
mares with 0 -< 2 cm intrauterine fluid were called resistant mares (n=47). Mares 
were further subdivided according to the result of pregnancy check into 4 groups: 
susceptible non-pregnant (SNP, n=16), susceptible pregnant (SP, n=9), resistant 
non-pregnant (RNP, n=26), and resistant pregnant (RP, n=21) mares (Fig. 2). 
 
2.3 Collection of uterine samples 
Two double-guarded uterine cytobrushes (Minitüb GmbH, Landshut, Germany) 
per mare were collected. The first cytobrush sample was used for the extraction of 
total RNA while the second one was used for cytological assessment. All samples 
were collected at mid-estrus (1-3 days before AI) when the mares had a dominant 
follicle (mean diameter of about 35 mm), a moderate endometrial edema, and a 
relaxed cervix. Samples were collected according to Dascanio and Ferris (2014) 
with some modifications. Briefly, mares were prepared as for AI. After removing 
feces from the rectum, the tail was wrapped and tied up. The perineal region was 
washed with non-residual soap and rinsed with fresh water at least three times to 
remove any obvious debris. Then, the area was dried using disposable paper 
towels. The veterinarian wore a clean, inverted rectal sleeve with sterile gloves on 
top. Sterile lubricant was put on the knuckles, thumb, and dorsal wrist area. The 
tip of double-guarded cytobrush was held and covered in the palm. With a slight 
rotating motion, the hand was passed into the vagina until the external cervical os 
was located, the index finger was introduced gently into the cervical canal, 
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followed by the cytobrush.After passing the cervical canal, the brush itself 
advanced into the outer, then the inner guards, to be in contact with the 
endometrium of the uterine body. Then, it was gently rolled for approximately 15 
seconds and retracted together with the inner guard from the outer guard, the outer 
guard was left in the mare until collecting the second sample to avoid additional 
manipulation with the cytobrush. The first cytobrush was directly inserted into a 1.5 
ml reaction tube with 350 µl of lysis buffer RNeasy micro kit (Qiagen, Hilden, 
Germany), rolled for 20 seconds. The reaction tubes were snap-frozen and stored 
in a liquid nitrogen tank until further analysis. 
A second new cytobrush with an inner guard only was inserted through the 
previous outer guard into the uterus. After collection of the sample, the brush was 
retracted back to the inner guard, then to the outer guard. and finally, the device 
was removed from the mare. The cytobrush was rolled on two microscope slides, 
air-dried, fixed, and stained with Diff-Quick for cytological evaluation. 
 
          2.4 Breeding management 
Using a standard gynecological procedure described by McCue (2014), the 
reproductive tract of the mares was examined using transrectal ultrasonography 
(Aloka Prosound 2, Hitachi, Japan) to determine the optimal time for uterine 
sampling and AI as well as to confirm the absence of any clinical symptoms of 
endometritis (i.e. an abnormal pattern of uterine edema in relation to follicular size, 
intrauterine fluid accumulation with a diameter ≥ 2 cm before or 24 hours after 
breeding, echogenic intra-uterine particles). The ovulation was induced, if the 
mares showed a preovulatory follicle ≥35 mm, moderate endometrial edema and 
a relaxed cervix by an intramuscular injection of 2500 IU human Chorionic 
Gonadotropin (Ovogest ® MSD Animal Health, Unterschleißheim, Germany). 
The mares were inseminated 24 h later using approximately 10-20 ml of cooled 





Fig. 1: Time schedule for reproductive management and sampling of the mares. 




          2.5 Post-breeding evaluation 
Twenty-four hours after insemination, the mares were checked by ultrasonography 
for the onset of ovulation and the amount of intrauterine fluid accumulation. Mares 
with detectable intrauterine fluids were checked again every 12 h and treated 
according to the amount and echogenicity of intrauterine fluids either with an 
intramuscular injection of 140 µg Carbetocin (Depotocin®, Veyx GmbH, 
Schwarzenborn, Germany) in case of anechogenic intrauterine fluid ≥ 2 cm in 
diameter or with intra-uterine lavage using 1-3 liters of warm (37O C) sterile 
physiological saline solution followed directly by Carbetocin injection in case of 
echogenic intrauterine fluid. Mares were classified as susceptible to PBIE if they 
showed delayed uterine clearance with ≥ 2 cm of intrauterine fluid 24 hours after 
the AI.  Mares with intrauterine fluid were checked and treated every twelve-hours 
(i.e. 36, 48, 60, 72 hours post-AI) until no fluid was detectable. 
 
          2.6 Pregnancy check  
The first pregnancy check was performed on Day14 (in case of double ovulation 
or Day 16 in case of single ovulation (Day 0 = day of ovulation). A second 
pregnancy check was performed 35 (±2) days after ovulation. 
 
          2.7 Assessment of the samples    
          2.7.1 Cytological assessment 
The cell smears mounted on glass slides were stained with Diff-Quick (RAL 
DIFF-QUIK™, Siemens Healthineers, UK) according to the manufacturer’s 
instructions. Briefly, the air-dried slides were dipped five times (1 sec. each) into 
fixative (methanol), solution 1 (xanthene), and solution 2 (thiazine), respectively. 
Afterwards, the slides were rinsed with distilled water and air-dried before 
microscopic assessment. 
Under a light microscope (Olympus CH2, Olympus, Tokyo, Japan) the slides were 
evaluated as described by Ferris et al. (2015). The initial evaluation was conducted 
at low magnification (4X or 10X) to determine the diagnostic value of the slides 
(enough cellularity to provide accurate interpretation ), if the slides were of high 
diagnostic value they were subsequently evaluated at a magnification of 400X 
over at least ten high-power fields (HPF) to determine the different cell types, 
particularly polymorphonuclear neutrophils (PMNs). If the slides were found to be 
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of insufficient cellularity to be of diagnostic value, new samples were collected on 
the same day. 
 
The average number of PMNs /HPF was determined and the inflammatory 
condition of endometrium was categorized as a) normal endometrium, if there 
were no PMNs, b,) mild inflammation if there were 1 to 2 PMNs, c) moderate 
inflammation if there were 3 to 5 PMNs, and d) severe inflammation if there were 
> 5 PMNs per HPF (Ferris et al. 2015). 
 
2.7.2 RNA extraction and quality measurement 
Total RNA extraction was performed for 27 samples with the best comparability 
(nine samples were selected from each SP, SNP, and RP groups), the mares had 
almost the same age, reproductive status and were inseminated with the same 
stallions. According to the manufacturer’s instructions, total RNA was extracted 
using the Qiagen RNeasy micro kit (Qiagen, Hilden, Germany) based on the 
protocol for purifying total RNA from animal and human tissue. Step number 
three in the manufacture protocol was the start of the procedures in the laboratory 
as the first two steps were done already after collecting the cytobrushes.  
The concentration and purity were measured by spectrophotometry using 
NanoDrop One (Thermo Fisher Scientific, Waltham, United States), while the 
quality of each RNA sample was measured using Agilent 2100 Bioanalyzer RNA 
6000 Nano assays (Agilent Technologies, Waldbronn, Germany). 
 
          2.7.3 RNA-sequencing and data analysis 
The RNA isolates were processed by standard Illumina mRNA sequencing using 
the Illumina Truseq stranded mRNA protocol, which was performed by the 
Functional Genomic Center Zurich (FGCZ), a core facility of the University of 
Zurich and ETH Zurich. The samples were barcoded and pooled and the pool was 
sequenced on an Illumina Novaseq 6000 (approximately, 30 million 100 bp single 
end reads per sample). The obtained sequence reads (Fastq files) were processed 
and mapped using a data analysis established on a local Galaxy server installation 
(ETH Zurich, Animal Physiology group) according to Blankenberg et al. 2010. 
Briefly, the Fastq files were subjected to quality control checking firstly utilizing 
'Fast QC' and 'Multi QC' tools, the adapter sequence was trimmed (for shorter 
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fragments where sequencing runs into the adapter) and 5 bp were removed from 
the 5′ end of the reads using Trim Galore (Kim et al. 2015). All the sequence reads 
were mapped to the reference equine genome assembly (EquCab3.0) from the 
National Center for Biotechnology Information (NCBI) by using the HISAT2 
tool. Feature Counts tool was used to count the number of sequence reads for the 
annotated genes, while Column Join on data tool was used to create a count table 
containing all samples. This table was filtered to remove genes with negligible 
read counts by using the counts per million (CPM) per sample filtering tool (Chen 
et al. 2017). 
The resulting read count table with CPM was used for statistical analysis in EdgeR 
(using GLM_robust) to identify the differentially expressed genes (DEGs) 
between susceptible pregnant, susceptible non-pregnant and resistant pregnant 
(Robinson et al. 2010). All DEGs between mare groups were filtered with a false 
discovery rate lower than 0.2 (FDR <20 %) using its corresponding p-value as a 
cut-off to compare the results efficiently. 
The online tool MAdb (Gene Symbol match, Ensembl compare database release 
95, Blast, https://madb.ethz.ch/) ( Bick et al. 2019) was used to acquire the 
corresponding human gene symbols and gene details for the DEGs. Then, these 
DEGs were subjected to hierarchical cluster analysis in MultiExperiment Viewer 
(MeV) using the HCL tool (Saeed et al. 2003). The functional classification and 
pathway analyses of DEGs were performed in the Metascape online tool ( 
https://metascape.org/) separately for lower and higher expressed genes in mare 
groups (Zhou et al. 2019). 
 
Fig. 2: Grouping of the mares according to susceptibility to persistent breeding 
induced endometritis and the result of pregnancy diagnosis
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2.8 Statistical analysis of the clinical data 
The correlation between the following variables: cytology results, intrauterine fluid 




3.1 Clinical findings 
From the 81 mares examined at the beginning of the study, 9 mares did not ovulate 
within 48 hours after the hormonal induction of ovulation. Therefore, these 9 mares were 
excluded from the study. Twenty-four susceptible mares showing anechogenic 
intrauterine fluid were treated using a Carbetocin injection 2-4 times in a 12-hour base. 
Only one susceptible mare developed echogenic intrauterine fluid that was treated using 
intrauterine lavage followed afterwards by Carbetocin injections, the injection was 
repeated until the fluids disappeared. 
36% of susceptible mares and 44.7% of resistant mares became pregnant. Three of the 
resistant pregnant mares had double ovulation, but none of them showed twins in the 
first pregnancy check. Only one pregnant mare from the resistant group lost the 
conceptus between the first and second pregnancy checks. All other mares with a 
positive pregnancy diagnosis on Days 14 or 16 were also pregnant around Day 35. 
 
3.2 Cytological assessment 
At the time of sampling, only 32% of susceptible mares showed a mild degree of uterine 
inflammation, while 38% of the resistant had a mild and 12 % a moderate uterine 
inflammation. In only 12% of the susceptible mares with positive cytology, a conceptus 
could be noticed during the pregnancy checks, while 21% of resistant mares with 
positive cytology became pregnant.  
There was a weak positive correlation between positive cytology results and the amount 
of uterine fluid accumulation (r= 0.25; P < 0.05). No significant correlation was 
determined between positive cytology and pregnancy results (r= -0.02; P > 0.05). 
 
3.3 RNA concentration and quality measurement 
The cytobrush technique provided uterine samples that were sufficient to yield an 
acceptable quantity of good quality RNA suitable for subsequent transcriptomic 
analysis. The total RNA concentration ranged from 15 to 731 ng/ μl, in addition, the 
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A260/A230 ratio was between 0.03 and 1.85 and the sample RNA Integrity Numbers 
(RIN) were between 8.6 and 10. After quality filtering of the fastq files, the results of the 
RNA sequencing revealed library sizes between 20.6 and 78.5 million reads per sample, 
with an average of 45.1 million reads. After sorting genes with neglectable read counts, 
a total of 14,725 genes were identified and used for differential gene expression analysis. 
 
3.4 Identification of differentially expressed genes between susceptible mares that 
did not   become pregnant and resistant mares that became pregnant 
The uterine transcriptome profiles showed significant variations between susceptible 
non- pregnant (SNP) and resistant pregnant (RP) mares. Sixty-six differentially 
expressed genes (DEGs) (FDR<0.2) have been identified among the two groups of 
mares, 21 genes were expressed significantly lower, while 45 were expressed 
significantly higher in SNP mares compared to RP mares (Fig. 3). 
 
The expressions of ADAM metallopeptidase with thrombospondin type 1 motif 6 
(ADAMTS6), uncharacterized LOC111768565 and ring finger protein 175 (RNF175) 
mRNAs were lower while the expressions of nucleoside diphosphate kinase B 
pseudogene (LOC100629802), epidermal growth factor (EGF) and ADAMTS like 
1(ADAMTSL1) mRNAs showed higher levels in SNP mares compared to RP mares. 
The hierarchical cluster analysis of the DEGs showed a separation of lower expressed 
(cluster1) and higher expressed (cluster 2) DEGs in SNP mares compared to RP mares 
(Fig. 3 a), while there is a partial separation between the mare groups (Fig. 3). The lower 






























Fig. 3: a) Heat map of hierarchical cluster analysis for DEGs between SNP mares and RP mares 
(FDR<0.2). Each line represents a gene, each column one sample. Red colors represent higher, 
while blue colors represent a lower expression of the gene compared to the mean of all samples 
(mean-centered values in log2 scale), the intensity of the red/blue colors represent the level of 
gene expression b) Heat map analysis of the mares. 
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Tab. 1: Genes with lower expression in susceptible mares that did not become pregnant 
compared to resistant mares that became pregnant 
 
               
Log FC: logarithm fold change, P-value: Probability value, FDR: false discovery rate. 
 




type 1 motif 6 




family member L1 
10840 -0.52 0.0006 0.1549 
APOE 100065481 apolipoprotein E 348 -0.92 0.0005 0.1458 
CCNE2 100055302 cyclin E2 9134 -1.66 0.0004 0.1399 
CD5L 100054450 CD5 molecule like 922 -1.28 0.0004 0.1395 
DTX1 100051299 
deltex E3 ubiquitin 
ligase 1 
1840 -0.73 0.0002 0.1208 
ELOVL2 100063624 
ELOVL fatty acid 
elongase 2 
54898 -0.74 0.0000 0.0231 




10129 -1.31 0.0000 0.0275 
GADL1 100057562 
glutamate 
decarboxylase like1  




interacting protein 3 
30818 -1.98 0.0003 0.1285 
LOC100056231 100056231 
saoe class I 
histocompatibility 
antigen 








LOC111773543 -2.17 0.0003 0.1328 




5909 -0.47 0.0003 0.1327 
RGS3 100052488 
regulator of G 
protein signaling 3 
5998 -0.71 0.0000 0.0306 
RNF175 100069989 
ring finger protein 
175 
285533 -2.25 0.0003 0.1285 
ROBO2 100068957 
roundabout 
guidance receptor 2 
6092 -1.89 0.0001 0.0928 
TNNC1 100051811 troponin C1 7134 -1.39 0.0000 0.0326 
ZNF704 100057981 
zinc finger protein 
704 
619279 -1.26 0.0000 0.0306 
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Tab. 2: Genes with higher expression in susceptible mares that did not become pregnant 
compared to resistant mares that became pregnant 
 
Log FC: logarithm fold change, P- value: Probability value, FDR: false discovery rate. 




144568 0.71 0.0004 0.1435 
ACER3 100063572 alkaline ceramidase 3 55331 0.65 0.00089 0.1986 
ACSL4 100054459 
acyl-CoAsynthetase 
long chain 4 
2182 0.61 0.0001 0.0928 




9590 0.81 0.0009 0.1980 
BMP2K 100059466 BMP2 inducible kinase 55589 0.47 0.0006 0.1620 
CA2 100050059 carbonic anhydrase 2 760 2.37 0.0005 0.1442 




27443 0.75 0.0000 0.0275 
CHRD 100067164 Chordin 8646 1.91 0.0000 0.0164 
CHRNA2 100060380 
Cholinergic-receptor 
nicotinic alpha 2 subunit 










4435 2.54 0.0000 0.0231 
CREG2 100059003 
cellular repressor of 
E1A stimulated genes 2 
200407 1.82 0.0001 0.0928 
EGF 106782874 epidermal growth factor 1950 5.22 0.0000 0.0202 
ETV4 100065121 
ETS variant 
transcription factor 4 
2118 1.42 0.0007 0.1756 





57678 0.93 0.0004 0.1396 
GPR37 100071585 G-protein  receptor 37 2861 1.40 0.0006 0.1549 
HSBP1L1 102150197 
heat shock factor 
binding protein 1 like 1 
440498 1.37 0.0006 0.1620 
IL23A 100034230 
interleukin 23 subunit 
alpha 
51561 1.60 0.0004 0.1399 
IQGAP2 100073279 
IQcontaining GTPase 
activating protein 2 
10788 1.03 0.0000 0.0306 
ITGB3 100009709 integrin subunit beta 3 3690 1.65 0.0005 0.1442 
KL 100064836 Klotho 9365 1.57 0.0008 0.1893 
LIN7A 100050683 
lin-7 homolog A, 
crumbs cell complex  





54658 1.84 0.0004 0.1395 
LOC100629802 100629802 
nucleoside diphosphate 
kinase B pseudogene 









LOC111776008 1.33 0.0003 0.1328 
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Tab. 2: Genes with higher expression in susceptible mares that did not become  
pregnant compared to resistant mares that became pregnant 
 
3.5 Overrepresented functional categories 
The corresponding human NCBI Entrez gene IDs of the lower and higher expressed 
DEGs were uploaded separately to the online Metascape Enrichment Analysis Tool to 
identify their over-represented functional categories (Fig.4).  
For genes with lower expression in the SNP group compared to the RP group, functional 
categories such as 1) developmental processes "Artery and cardiac chamber 
development", 2) positive regulation of biological process "axon guidance, positive 
regulation of cell development, and regulation of cell differentiation " and 3) locomotion 
“Hallmark of xenobiotic metabolism and enzyme activator activity " were 
overrepresented, while the higher expressed DEGs were enriched for 1) metabolic 
processes "glycosaminoglycan and mucopolysaccharide metabolic process ", 2) 
developmental process "tissue remodeling, receptor complex and regulation of peptidyl-
tyrosine phosphorylation" 3) response to stimulus "tissue morphogenesis" and 4) 
signaling "cellular response to growth factor stimulus and negative regulation of cell 
differentiation" functional categories in SNP compared to RP mares (Tab. 3).
Gene 
Symbol 
Gene ID Description 
Human 
ID 
logFC P- value FDR 
MATN2 100055555 matrilin 2 4147 1.46 0.0007 0.1756 
MCTP1 100073232 
multiple C2 and 
transmembrane domain 
containing 1 
79772 1.03 0.0003 0.1285 
PAQR3 100059505 progestin adipo Q receptor 3 152559 0.59 0.0003 0.1290 
LYNX1 100066475 Ly6/neurotoxin 1 66004 0.87 0.0003 0.1285 
PDE2A 100052619 phosphodiesterase 2A 5138 1.45 0.0003 0.1328 
PPARGC1A 100055716 PPARG coactivator 1 alpha 10891 1.52 0.0000 0.0190 
PSCA 100063721 prostate stem cell antigen 8000 1.77 0.0005 0.1442 
SDC2 100059727 syndecan 2 6383 1.15 0.0002 0.0997 
SEMA3C 100054706 semaphorin 3C 10512 1.78 0.0000 0.0275 
SEMA6A 100073147 semaphorin 6A 57556 0.62 0.0000 0.0384 
SH3D21 100069289 SH3 domain containing 21 79729 1.19 0.0005 0.1442 
SLC4A4 100049977 
solute carrier family 4 
member 4 
8671 1.83 0.0000 0.0032 
SPOCK2 100063582 
SPARC (osteonectin), 
kazal like domains 2 
9806 1.76 0.0006 0.1575 
TFPI2 100051361 
tissue factor pathway 
inhibitor 2 
7980 1.47 0.0001 0.0928 
TM4SF1 100050742 
transmembrane 4 L six 
family member 1 
4071 0.92 0.0003 0.1328 
TMEM117 100050185 transmembrane protein 117 84216 0.56 0.0005 0.1458 
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Tab. 3: Metascape enrichment analysis of DEGs in susceptible mares that did not 




Most informative categories of Metascape 
enrichment analysis 
LogP Genes 




APOE, ROBO2, ADAMTS6, TNNC1 
Axon guidance, positive regulation of cell 
development, regulation of cell morphogenesis 




RGS3, ROBO2, PLXNC1, APOE, 
RAP1GAP, DTX1 
 





APOE, EPHX1, RAP1GAP, RGS3, 
CCNE2 
 




APOE, ALDH1L1, GADL1 
 




APOE, TNNC1, KCNIP3 
 
Higher expressed DEGs 
 
  
Glycosaminoglycan metabolic process, 




CD44, EGF, SDC2, SPOCK2, CHST15 
 
Microvillus, tissue remodeling, receptor complex 




CA2, CD44, ITGB3, IQGAP2, 
SEMA3C, IL23A, EGF, MATN2, 
TFPI2, SDC2,  





CA2, CD44, EGF, ITGB3, MATN2, 
CITED1, CHRD, SEMA3C, GPAM 
 
Cellular response to growth factor stimulus, 




CD44, ITGB3, CITED1, PDE2A, 
CHRD, KL, PPARGC1A, SEMA6A, 
BMP2K, SEMA3C, PAQR3, EGF, 
ACSL4, TM4SF1 
 
NABA MATRISOME ASSOCIATED, 
regulation of chemotaxis. 
-4.42 
 
EGF, SDC2, CHRD, SEMA3C, IL23A, 
SEMA6A, ADAMTSL1, A2ML1, 
ITGB3, AKAP12, SPOCK2, KL, 
LYNX1,  
 
Regulation of MAPK cascade, regulation of 






CD44, EGF, GPR37, PSCA, KL, 
AKAP12, SEMA6A, PAQR3 
 
MAPK family signaling cascades, 





EGF, ETV4, ITGB3, KL, PAQR3, 
BMP2K, MCTP1, IQGAP2, SDC2, 
SEMA6A 
 
Regulation of signaling receptor activity, negative 




EGF, PSCA, PPARGC1A, LYNX1, 
CD44, PDE2A, SEMA6A, PAQR3 
 
Pigment metabolic process, cellular response to 





UGT1A1, GPAM, AKAP12, 
PDE2A, GPR37, 
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Fig. 4: Metascape analysis: most enriched categories of genes with lower and higher expression 
in susceptible mares that did not become pregnant compared to resistant mares that became 
pregnant. The color intensity represents the level of functional enrichment. 
 
 
Higher expressed DEGs 
 
LogP Genes 
Positive regulation of carbohydrate 
metabolic process, positive 





EGF, SLC4A4, PPARGC1A, KL, CHST15, 
UGT1A1, ACSL4, FADS3, GPAM, SDC2, 
PDE2A, CITED1, SPOCK2, ACER3, CECR2 
 





GPR37, CITED1, ACER3, GPAM 
 












CHRNA2, ITGB3, PDE2A, LIN7A 
 




EGF, MATN2, SPOCK2, ACER3, MCTP1 
 














3.6 Identification of differentially expressed genes between susceptible mares that  
 become pregnant and susceptible mares that did not become pregnant 
A total of sixty DEGs (FDR<0.2) were detected in the comparison of SP mares and SNP 
mares, thirty- nine were significantly lower, whereas twenty-one were higher expression 
in SP mares relative to SNP mares. The expression of aldo-keto reductase family 1 
member C23 (LOC100070570), protein kinase C gamma (PRKCG) and epidermal 
growth factor (EGF) mRNAs was lower, while the expression of membrane-spanning 4-
domains subfamily A member 4A (LOC100061296), growth differentiation factor 10 
(GDF10) and Rh family C glycoprotein (RHCG) mRNAs was higher in SP mares 
compared to SNP mares. 
 
The hierarchical cluster analysis demonstrates separation of the lower-expressed (cluster 
1) and higher-expressed (cluster 2) DEGs in SP mares vs. SNP mares (Fig. 5a), however, 
there is only a partial separation between the mare groups (Fig. 5b). The DEGs of lower 

























































































































































Fig. 5: a) Heat map of hierarchical cluster analysis for DEGs between SP mares and SNP mares 
(FDR<0.2). Each line represents a gene, each column one sample. Red colors represent higher 
while, blue colors represent the lower expression of the gene compared to the mean of all 
samples (mean-centered values in log2 scale), the intensity of the red/blue colors represent the 







Tab. 4: Genes with lower expression in susceptible mares that become pregnant 















Gene Symbol Gene ID Description 
Human 
ID 
logFC P- value FDR 
A2ML1 100061421 alpha-2-macroglobulin like 1 144568 -1.17 0.0003 0.0963 




79868 -0.83 0.0006 0.1630 
CAV1 100055975 caveolin 1 857 -1.99 0.0000 0.0117 
CECR2 100055261 
CECR2 histone acetyl-lysine 
reader 
27443 -1.02 0.0000 0.0088 
CHRNA2 100060380 
cholinergic receptor nicotinic 
alpha 2 subunit 




1184 -0.76 0.0002 0.0812 
COL4A3 100037402 
collagen type IV alpha 3 
chain 
1285 -1.51 0.0001 0.0579 
COL5A2 100054421 collagen type V alpha 2 chain 1290 -1.28 0.0004 0.1193 
DNASE1L3 100057863 deoxyribonuclease 1 like 3 1776 -1.97 0.0002 0.0812 
EGF 106782874 epidermal growth factor 1950 -3.50 0.0004 0.1265 
FAM20A 100062707 
FAM20A golgi associated 
secretory pseudokinase 
54757 -1.20 0.0001 0.0633 
FAT1 100050525 FAT atypical cadherin 1 2195 -0.76 0.0001 0.0756 
FBN1 100055741 fibrillin 1 2200 -1.62 0.0000 0.0484 
FN1 100034189 fibronectin 1 2335 -1.62 0.0008 0.1952 








50939 -0.98 0.0002 0.0834 
IQGAP2 100073279 
IQ motif containing GTPase 
activating protein 2 
10788 -1.08 0.0001 0.0756 
KIF3C 100055794 kinesin family member 3C 3797 -1.27 0.0000 0.0210 
LAMB1 100060360 laminin subunit beta 1 3912 -1.96 0.0000 0.0279 
LIMCH1 100063373 
LIM and calponin homology 
domains 1 
22998 -0.93 0.0000 0.0473 
LOC100065083 100065083 
solute carrier family 35 
member E2 
728661 -0.47 0.0001 0.0579 
LRRK2 100052935 leucine rich repeat kinase 2 120892 -1.29 0.0004 0.1193 
PRKCG 100062549 protein kinase C gamma 5582 -3.95 0.0000 0.0473 





Tab. 4: Genes with lower expression in susceptible mares that become pregnant 
compared to susceptible mares that did not become pregnant. 
 
 




















major allergen Can f 
1-like 
3933 -3.21 0.0004 0.1214 
LOC100070570 100070570 
aldo-keto reductase 
family 1 member C23 
LOC100070570 -4.09 0.0001 0.0586 




LOC111774719 -0.60 0.0000 0.0117 
SCUBE1 100071128 
signal peptide, CUB 
domain and EGF like 
domain containing 1 
80274 -2.77 0.0001 0.0756 




27111 -2.44 0.0003 0.1017 
SLC38A1 100050256 
solute carrier family 
38-member 1 
81539 -0.69 0.0002 0.0776 
SLC4A4 100049977 
solute carrier family 
4-member 4 




221178 -0.59 0.0008 0.2011 
XCR1 100065485 
X-C motif chemokine 
receptor 1 
2829 -1.52 0.0002 0.0776 
ZFHX2 100052278 
zinc finger homeobox 
2 
85446 -0.69 0.0004 0.1256 
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Tab. 5: Genes with higher expression in susceptible mares that become pregnant 
compared to susceptible mares that did not become pregnant. 
 
Log FC: logarithm fold change, P-value: Probability value, FDR: false discovery rate.  




147 1.83 0.0007 0.1880 
CTSB 100060963 cathepsin B 1508 0.38 0.0006 0.1600 
CXCL16 100061442 
C-X-C motif 
chemokine ligand 16 
58191 0.55 0.0001 0.0510 
ELOVL2 100063624 
ELOVL fatty acid 
elongase 2 
54898 0.66 0.0007 0.1880 









2662 3.78 0.0000 0.0117 
GPBAR1 100055590 
G protein-coupled 
bile acid receptor 1 





3248 1.04 0.0003 0.1028 
HSPB1 100059763 
heat shock protein 
family B (small) 
member 1 
3315 0.55 0.0001 0.0642 
KDR 100033959 
kinase insert domain 
receptor 
3791 1.48 0.0000 0.0117 
KLRG2 102148132 
killer cell lectin like 
receptor G2 
346689 0.79 0.0002 0.0775 
LGR5 100064565 
leucine rich repeat 
containing G protein-
coupled receptor 5 
8549 2.10 0.0008 0.2065 
LMCD1 100058957 
LIM and cysteine 
rich domains 1 




A member 4A 




LOC111768565 3.18 0.0002 0.0776 
RGS9 100053338 
regulator of G protein 
signaling 9 
8787 0.70 0.0002 0.0776 
RHCG 100069692 
Rh family C 
glycoprotein 
51458 3.66 0.0003 0.1191 
SLC22A3 100058287 
solute carrier family 
22 member 3 




6715 0.86 0.0007 0.1938 
TNNC1 100051811 
troponin C1, slow 
skeletal and cardiac 
type 
7134 1.28 0.0000 0.0473 
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3.7 Overrepresented functional categories 
The overrepresented functional categories of genes with lower expression in SP mares 
compared to SNP mares were 1) cellular component organization "degradation of the 
extracellular matrix (ECM), focal adhesion, ECM-receptor interaction, PI3K-Akt 
signaling pathway", 2) regulation of biological processes "negative regulation of 
proteolysis and hydrolase activity" and 3) developmental processes "Cell junction 
assembly and positive regulation of peptidase activity". While the genes with higher 
expression were enriched for 1) response to stimulus "Cellular response to growth factor 
stimulus, epithelial cell proliferation, positive regulation of MAPK cascade and regulation 
of vasculature development ", 2) signaling "response to toxic substance, response to 
estradiol, urogenital system development" 3) cell proliferation "second- messenger-
mediated signaling" and 4) reproductive processes "Developmental process involved in 
reproduction, collagen-containing extracellular matrix " functional categories in SP 
compared to SNP mares (Tab. 6, Fig. 6). 
Fig. 6: Metascape analysis: most enriched categories of genes with lower and higher 
expression in susceptible mares that become pregnant compared to susceptible mares that 
















Tab.6: Metascape enrichment analysis of DEGs susceptible mares that become 












Most informative categories of 
Metascape enrichment analysis 
LogP Genes 
Lower expressed DEGs    
 
Degradation of the extracellular matrix, 
ECM organization, focal adhesion, ECM-




COL4A3, COL5A2, FBN1, FN1, 
LAMB1, ADAMTS5, SCUBE1, SDC2, 
CAV1, IMPG2, EGF, PRKCG, FAM20A, 
LRRK2, FAT1 
Peptidase regulator activity, negative 
regulation of proteolysis, negative 
regulation of hydrolase activity. 
  
-5.97 
CAV1, COL4A3, FN1, LCN1, WFDC12, 
A2ML1, PRKCG, LRRK2, 
IQGAP2 
Syndecan interactions, positive regulation 
of peptidase activity, cell junction 
assembly.  
-5.03 
COL5A2, FN1, SDC2, CAV1, PRKCG, 
EGF, KIF3C, COL4A3, GLRX, LIMCH1 
Rho GTPase binding, positive regulation 
of proteolysis, cation homeostasis. 
  
-4.18 
CAV1, IQGAP2, LRRK2, SPATA13, 
COL4A3, EGF, FN1, PRKCG, CHRNA2, 
GLRX, SLC4A4, FAM20A, ZNF462, 
XCR1 
Regulation of actin cytoskeleton, platelet 
activation, signaling and aggregation, 





EGF, FN1, IQGAP2, SPATA13, PRKCG, 
LRRK2 




FAT1, IQGAP2, LRRK2, SPATA13, 
LIMCH1, RFLNB, COL5A2, CAV1 
Secondary active transmembrane 
transporter activity, inorganic cation 




CLCN5, SLC4A4, SLC38A1, SLC35E2B, 
CAV1, GLRX, XCR1, LCN1 
 
NABA MATRISOME ASSOCIATED, 
NABA ECM regulators. 
  
-3.05 
EGF, SDC2, ADAMTS5, FAM20A, 
SCUBE1, A2ML1, LAMB1, ALG13 
Cellular component disassembly. 
  
-2.81 
CAV1, DNASE1L3, ADAMTS5, CECR2, 
SCUBE1 
Eye morphogenesis, calcium ion binding. 
  
-2.80 
COL5A2, FAT1, FBN1, DNASE1L3, 
EGF, SCUBE1 
Regulation of neurotransmitter levels, 
transmission across chemical synapses. 
  
-2.69 
CAV1, PRKCG, SLC38A1, LRRK2, 
CHRNA2 
 
Negative regulation of cell differentiation. 
  
-2.25 
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The present study is to the best of our knowledge the first clinical prospective investigation of 
using RNA-Seq analysis of uterine cytobrush samples to identify RNA markers for the 
susceptibility to PBIE by comparing the uterine transcriptome profiles in susceptible mares that 
did not become pregnant (SNP) in comparison to resistant mares that became pregnant (RP). 
Furthermore, the uterine transcriptome profiles of susceptible mares that became pregnant and 
susceptible that did not become pregnant (SP) were compared. 
 
4.1 Clinical findings 
We included only mares ≥ 10 years, because such mares may have a higher risk of susceptibility 
to the PBIE (Carnevale and Ginther 1992, Grüninger et al. 1998, Woodward et al. 2012). Older 
mares are known to have more often a poor vulvar conformation, a cervical dilation and a lower 
lymphatic drainage, which can be involved in accumulation of intrauterine fluids post AI 
(Bucca et al. 2008, Canisso et al 2016). Although intrauterine fluid is often associated with a 
positive cytological finding (Burleson et al. 2010), we found a weak positive association 
between positive uterine cytology results before AI and the intrauterine fluid accumulations 
Higher expressed DEGs  LogP Genes 
Cellular response to growth factor 
stimulus, epithelial cell proliferation, 
positive regulation of MAPK cascade, 





FGF9, GDF10, HPGD, HSPB1, KDR, 
SRD5A1, LGR5, GPBAR1, ADRA1B, 
CXCL16  
 
Response to toxic substance, response to 













ADRA1B, KDR, LGR5, LMCD1, TNNC1 
 
Developmental processes involved in 
reproduction, collagen-containing 
















after AI. Intrauterine fluid is a common clinical sign of endometritis (Allen and Pycock 2010), 
however only mares with severe uterine inflammation according to cytological findings (>5 
PMNs/field) showed an accumulation of intrauterine fluids (Burleson et al. 2010). Moreover, 
Escherichia coli, one of the most common uterine isolates in the equine uterus (Albihn et al. 
2003), is usually not associated with PMNs (Overbeck et al 2011). These observations may 
explain the low association between positive cytological findings and uterine fluid 
accumulations in our study.  
 
 Besides, we found no positive cytology had no negative effect on pregnancy rates. In contrast, 
Riddle et al. (2007) reported that presence of >2 PMNs per microscopic high-power field was 
associated with reduced pregnancy rates. Also, this discrepancy may be due to using different 
interpretation methods of the cytology slides. Riddle et al. (2007) considered the presence of 
0–2 neutrophils per microscopic high-power field as a non-inflamed uterus, while we 
interpreted findings with 1 to 2 PMNs already as positive. 
 
4.2 Lower expressed genes in susceptible mares that did not become pregnant in 
comparison to resistant mares that became pregnant 
The comparative transcriptome analysis demonstrated differences in mRNA expression 
profiles among mare groups, 66 DEGs were identified by comparing SNP mares and RP mares 
and 60 DEGs between SP mares and SNP mares. In the following, selected DEGs potentially 
important for fertility prediction are discussed. Genes of lower expression in SNP mares were 
most significantly enriched for biological processes related to the regulation of cell 
development and differentiation. We suggest that the genes apolipoprotein E (APOE) and 
Roundabout 2 (ROBO2) may play a role in mares' resistance to PBIE based on their known 
roles in the regulation of steroid hormone metabolism and neutrophil chemotaxis. Such genes 
were found to be lower expressed in SNP mares compared to RP mares. 
The protein encoded by the gene APOE belongs to the apolipoprotein family which is known 
as lipid transporters, enzyme co-factors, and receptor ligands (Mahley and Rall 2000, 
Ganfornina et al. 2008).  APOE interacts with the low-density lipoprotein receptor (LDLR). 
Such interaction is essential for normal catabolism and cellular uptake of triglyceride-rich 
lipoprotein in peripheral tissues participating in immune modulation, cell migration, 
neurodevelopment, and synaptic plasticity (Stolt and Bock 2006). Several of these functions 




In agreement with our findings, lower levels of fertility have been reported in APOE knock- 
out mice (Collazo et al. 2012). As APOE regulates steroid hormone metabolism any alteration 
in the mRNA expression of the APOE gene adversely affects some uterine functions like 
impairing the implantation process (Germeyer et al. 2013). 
 
In cattle, the expression of APOE is found to be upregulated in the normal endometrium during 
the estrous phase (Bauersachs et al. 2005). Additionally, this gene is reported to be highly 
expressed in the normal endometrium of women during the implantation window (Kao et al. 
2002). As there is a correlation between APOE mRNA expression and impaired lipid levels 
(cholesterol, triglyceride, low-density lipoprotein) which may be harmful to mother and fetus 
(Descamps et al. 2005, Hieronimus et al. 2005, Chuang et al. 2009), it has been proposed that 
the APOE gene could be a potential factor in the reproductive performance of a woman 
affecting her opportunity to have a successful pregnancy (McGladdery and Frohlich, 2001).  
In addition, it has been demonstrated that the uterus of women of high fecundity (potential 
fertility) expresses high APOE levels that subsequently improves the half-life levels of 
reproductive steroid hormones (Jasienska et al. 2015). The expression of the APOE gene in the 
human endometrium is found to be reduced in the case of endometriosis compared to a healthy 
endometrium during both the proliferative and secretory phases of the menstrual cycle 
(Sundqvist et al. 2012). 
 
APOE protein mediates binding and neutralizing the microbial cell wall lipopolysaccharide 
(LPS), and reportedly suppresses the systemic inflammatory responses to the LPS intravenous 
injection in wild mice (Wang et al. 2009). In addition, APOE has been proven to decrease the 
recruitment of neutrophils and macrophages into the bronchoalveolar lavage in wild mice (Ni 
et al. 2013), indicating potential anti-inflammatory and antioxidant activities of APOE to 
minimize the severity of inflammatory diseases (Yao et al. 2016). 
The protein encoded by the gene ROBO 2 belongs to a superfamily of immunoglobulins which 
works as transmembrane receptors for SLITs ligands. In several body systems, SLITs mediate 
cell migration and polarization of different cell types (Tessier-Lavigne and Goodman 1996). 
Three (SLIT 1–3) proteins bind to each of the four (ROBO 1–4) receptors (Legg et al. 2008). 
The ROBO2 encoded protein is a SLIT2 transmembrane receptor, which plays a role in axon 
guidance during nervous system development (Hinck, 2004), as well as in regulating the 




In women, it has been reported that the SLIT / ROBO pathway may have key roles in the 
reproductive system (Dickinson et al. 2008, Tong et al. 2019). In agreement with our results, 
the mRNA expression of the ROBO 2 gene is found to be higher in the uterus in women during 
their follicular phase of menstrual cycle, indicating the  significant role of SLIT / ROBO 
pathway during normal endometrial development (Duncan et al. 2010). 
 
SLIT / ROBO pathway acts as a powerful inhibitor of chemotaxis of circulating neutrophils 
towards various inflammatory stimuli, preventing the migration of many forms of 
inflammatory cells, like neutrophils, macrophages, T-lymphocytes and dendritic cells to 
various chemo-attractive signals, which could function as a highly effective anti-inflammatory 
agent (Guan et al. 2007, Prasad et al. 2008, Wu et al. 2001). 
 
Nevertheless, many studies have reported the role of Slit2 / Robo-1 in the control of 
inflammation, we assume that the binding of SLIT2 to ROBO 2 may exert a similar anti-
inflammatory effect, since ROBO 1 and ROBO 2 are structurally identical, besides, SLIT2 has 
the same affinity for both ROBO1 and ROBO 2 receptors (Dickinson and Duncan 2010). 
 
4.3 Higher expressed genes in susceptible mares that did not become pregnant in 
comparison to resistant mares that became pregnant 
In the SNP mares some genes that enriched for cell-cell and cell-extracellular matrix 
interactions, glycosaminoglycan metabolism and tissue remodeling were highly expressed. We 
assume that the higher expression of Cluster domain 44 (CD44), Integrin beta 3 (ITGB3), 
Epidermal growth factor (EGF) and interleukin-23 subunit alpha (IL23A) genes in SNP 
compared to RP mares mediates the development and/or maintenance of uterine inflammation. 
 
The gene CD44 is encoded for a cell-surface glycoprotein receptor of many well-known ligands 
including hyaluronic acid (HA), osteopontin (OPN), collagens, and matrix metalloproteinases 
(MMPs) (Goodison et al. 1999) that engage in many cellular activities including the activation, 
recirculation and homing of T-lymphocytes, hematopoiesis, response to bacterial infection, HA 
uptake/degradation, lymph node homing, prothymocyte homing, cell aggregation, chemokine 
release and inflammation (Haynes et al. 1991, Lesley et al. 1993), but these CD44 functions 
depend on their ligand specificity (Weber et al. 1996).  
 
Hyaluronan is a glycosaminoglycan of the extracellular matrix that mainly exerts its function 
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through binding specifically to CD44. It is a widely distributed adhesion protein that mediates 
cell-cell and cell-microenvironment interactions (Johnson and Ruffell 2009). HA-CD44 is 
crucial for the development of inflammatory responses like apoptosis and lymphocyte 
migration. Additionally, several lines of evidence link CD44 to fibroblast adhesion, migration, 
and fibrosis development (Evanko et al 2007, Bajorath 2000). 
CD44 expression has been immunolocalized in luminal epithelia of equine ovaries, fallopian 
tubes and uterus, as well as in mesenchymal elements requiring frequent remodeling (e.g., 
fibroblast blood vessels, myocytes, and tissue walls), in the uterus, CD44 receptor is mainly 
located on the endometrial surface of the epithelium and stromal leukocytes (Rodriguez et al 
2011). 
 
In bovine and porcine species, the expression of CD44 is observed at various stages of oocyte 
and embryo development and is also implicated in sperm preservation and fertilization (Yokoo 
et al. 2002, Furnus et al. 2003). Besides, different CD44 isoforms have been found in human 
reproductive tissues, like cervical epithelium (Woerner et al. 1995) endometrial stromal and 
epithelial cells (Behzad et al. 1994) follicular fluid (Ohta et al. 2001) placenta, oocytes, early 
embryos, and sperm cells (Aplin 1997, Goshen et al. 1996, Ohta et al. 1999, Bains et al. 2002). 
 
It is also believed that HA-CD44 pathway is correlated to reproductive pathology, for instance, 
the CD44 receptor has been implicated in the development and metastasis of ovarian tumors 
and uterine carcinomas in women (Qu et al. 2001, Stokes et al. 2002). Whereas reproductive 
neoplasms are rare in mares, chronic inflammatory degenerative changes are often identified 
in old multiparous mares. Several pieces of evidence link CD44 to fibroblast adhesion, 
migration, and fibrosis development, for instance, CD44 receptors are frequently expressed in 
newly formed fibrotic tissue moreover. Furthermore, anti-CD44 may inhibit fibroblast invasion 
of a fibrin matrix, indicating interruption of the CD44 role can reduce or prevent fibrotic 
reaction (Svee et al. 1996).  
 
Endometrial fibrosis is a chronic disease that can arise from intrauterine infections, irritant 
topical treatments, or multiple pregnancies; fibrosis relates to infertility through impairing 
glandular and epithelial function, resulting in embryonic mortality during the first trimester of 





HA-CD44 is reported to be involved in pathological conditions that may cause reproductive 
failure in mares due to its role in the development of inflammation and fibrosis (Rodriguez et 
al. 2011).  
 
In agreement with our findings, there was no expression CD44 observed in the follicular phase 
of the menstrual cycle in the normal women endometrium (Yaegashi et al. 1995, Poncelet et 
al. 2002). Furthermore, it has been documented that the increased expression and significant 
endometrial shedding of CD44 may have a role in the pathogenesis of endometriosis in women 
(Griffith et al. 2010, Pazhohan et al. 2018). 
 
Our results may refer to the proinflammatory function of CD44 which facilitates leukocyte 
extravasation and chemotaxes, induces inflammatory gene expression in leukocyte cells and 
contributes to matrix remodeling (Knudson, et al. 1993, DeGrendele et al. 1996, Puré and Cuff 
2001). Additionally, evidence that CD44 plays a key role in many inflammatory diseases was 
obtained by studies wherein anti-CD44 reduced inflammation in murine models for 
inflammatory bowel disease, collagen- and proteoglycan-induced arthritis (Zeidler et al. 1995), 
skin inflammation (Camp et al. 1993), autoimmune encephalomyelitis (Brocke et al. 1999). 
 
Endometrial receptivity is widely investigated in women. It could be defined as the ability of 
uterine mucosa to support successful embryonic implantation. Endometrial receptivity is 
mediated by molecular and genetic elements, like cytokines, adhesion molecules (integrins), 
growth factors (EGF, TGF-β, FGF), transcription factors (Hox), and ovarian hormones 
(Achache and Revel 2006).  
 
The gene ITGB3 encodes for a cell-surface adhesion protein, which belongs to the integrin 
family that is cation-dependent transmembrane receptors composed of α and β subunits (Hynes 
1992). ITGB3 is present in two combined forms either with the alpha IIb chain (Integrin alpha-
IIb / beta-3 (αIIbβ3) or with integrin alpha-V / beta-3 (αvβ3). It is a cell adhesion coreceptors 
of the immunoglobulin that engage in cell adhesion and cell-surface mediated signaling (Hynes 
1992, Brakebusch and Fassler 2003). 
 
Integrins are related to various physiological processes including reproductive biology (Bowen 
and Hunt 2008) for instance, integrins are considered necessary for fertilization, embryo 
implantation and placental growth (Lessey et al. 1992, Damsky et al. 1993). Integrin expression 
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patterns are reported in pregnant and cycling cows (Kimmins and MacLaren 1999, McIntyre 
et al. 2002), sows (Bowen et al. 1996), women (Lessey et al. 1996) and mice (Illera et al. 2000).  
 
In equine, the transcriptomic analysis of uterine biopsies on day 16 of pregnancy reveals 
overrepresentation of the integrin signaling pathway. It is hypothesized that the endometrial 
integrin αvβ3 interacts with conceptus-derived fibrinogen, contributing significantly in the 
cessation of conceptus mobility and fixation at days 15–16 of pregnancy (Klein 2015).  
 
Integrin αvβ3 is documented to appear abruptly in the luminal and glandular endometrial 
epithelium at the putative implantation time in women coinciding with the increase in 
progesterone during the implantation window (Lessey 1998), while the high levels of estrogen 
(E2) prevent the implantation of the embryo. E2 is reported to decrease the expression pattern 
of integrin αvβ3 in women of with unexplained infertility (Lessey et al. 1995). E2 and 
progesterone (P4) tend to regulate the patterns of expression of integrins. Elevated blood E2 
levels have been correlated with a substantial decrease in the level of integrin αvβ3 expression 
in human uterine biopsy samples (Chen et al. 2016), which agrees with our findings regarding 
the low expression of ITGB3 in RP mares due to the high levels of E2 at the sampling time in 
estrus. Interestingly, the SNP mares showed high uterine expression of ITGB3 regardless of 
the high E2 concentrations. 
 
On the other hand, it was shown that ITGB3 mRNA expression in the normal bovine 
endometrial epithelial cells was downregulated following the inoculation of bacterial 
lipopolysaccharides (Guowu et al. 2019). However, this result was obtained from an in vitro 
culture of endome¬trial epithelial cells without any information about the reproductive 
hormone levels in the uterus before cultivation. 
 
The high uterine expression of ITGB3 in SNP mares despite the high E2 concentrations in 
estrus can be attributed to the potential role of ITGB3 in the regulation of macrophage- related 
inflammatory reactions through activation of NF-κB. It is believed that the activation of 
integrin αVβ3 sustains the chronic inflammatory reactions under pathological conditions 
(Antonov et al. 2011). It is assumed that Integrin αVβ3 plays an important role in the onset 
and/or progression of a variety of human inflammatory diseases, such as osteoporosis and 




 In the present study, we assume that the SNP mares may have shown a certain degree of 
chronic uterine inflammation resulting in a high expression of ITGB3. 
 
EGF is a member of the epidermal growth factor superfamily. It stimulates cell growth, 
proliferation and differentiation in a wide range of tissues through binding to its receptor 
(EGFR) on the cell surface. Such binding triggers a signal transduction cascade resulting in a 
wide range of biological changes within the cell, like increasing the intracellular calcium levels, 
enhancing glycolysis and protein synthesis (Fallon et al. 1984). 
 
The uterine mRNA expression of EGF gene is associated with elevated serum estradiol 
concentrations during the follicular phase of menstrual cycle in women and rhesus monkeys 
(Imai et al. 1995, Ace and Okulicz 1995). In contrary, the mRNA expression of EGF in equine 
uterus has a different pattern of hormonal regulation compared to the previously mentioned 
species. In ovariectomized, prepubertal, and anestrous mares that were not under the influence 
of gonadal steroid hormones there was no evidence of EGF gene expression. Similarly, a tiny 
levels of EGF gene expression was found in the normal mares’ uterus during estrus under the 
influence of estrogen. Moreover, estrogen treatment was unable to upregulate EGF gene 
expression in the endometrium of anestrous and ovariectomized mares. This indicates that the 
uterine mRNA expression of EGF in equine is not estrogen-dependent, but progesterone-
dependent (Gerstenberg et al. 1999). 
 
Endometrial EGF in mares appears to play a significant role during the formation of an 
epitheliochorial placenta, and glandular histotrophic development (Gerstenberg et al. 1999). 
Klein (2015) also reported that on day 16 of pregnancy, equine endometrium exhibits a high 
EGF mRNA expression. 
 
In healthy cows, the uterine EGF protein levels are recorded to be at the maximum on days 2– 
4 and 13–14 and at the minimum on day 7 of the estrous cycle, while in repeat breeder cows 
the 2 peaks in the endometrial EGF profile are absent (Katagiri et al. 2004, Katagiri et al. 2006). 
The EGF concentrations in the uterus of fertile cattle display a cyclic shift during the estrous 
cycle. The loss of a cyclic EGF profile during the estrous cycle may reduce fertility in dairy 
cows (Katagiri et al. 2013).  
In our study, RP mares showed low levels of EGF expression during estrus which agrees with 
the findings of Gerstenberg et al. (1999). Surprisingly, on the other hand, the SNP mares 
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exhibited high expression of EGF irrespective of the high level of estrogen at the time of 
sampling. We assume that an abnormal increase of EGF expression in SNP mares may increase 
its susceptibility to PBIE due to the estrogen-like effects of EGF which is known to be an 
important mediator of estrogen action in the reproductive tract (Nelson et al. 1991). One of 
these effects is that estradiol can promote the pro-inflammatory response of the uterus via 
regulating the expression of various cytokines (Tibbetts et al. 1999). 
 
Overall, our findings in RP mares regarding the low endometrial expression of ITGB3 and EGF 
in healthy mares during the estrus phase confirm the previous equine studies. on the other hand, 
the abnormally increased expression of both genes in SNP mares may indicate their abnormal 
response to reproductive hormones which may increase the susceptibility to develop PBIE. 
More studies are required to explain the influence of E2 and P4 hormones on the expression of 
these genes during the estrous phase in fertile and infertile mares, in particular with evidence 
that infertile women with endometriosis have partial resistance to reproductive hormones 
during the menstrual cycle (Burney et al. 2007, Bulun 2010). 
The IL23A gene encodes for a protein forming the interleukin IL-23. IL23 is a heterodimeric 
cytokine essential for the inflammatory response against infection through upregulating the 
matrix metalloprotease (MMP9) and enhancing angiogenesis. IL-23 modulates its impact on 
both innate and adaptive immune systems that express IL-23 receptors such as T helper 17 
(Th17) cells that in turn release IL-17. Proinflammatory cytokines enhance T cell priming and 
trigger the output of other proinflammatory molecules such as IL-1, IL-6, TNF-alpha, NOS-2 
and chemokines resulting in acute inflammation in peripheral tissues (Memari et al. 2015). IL- 
23 and IL-17 have been associated with the pathogenesis of some autoimmune disorders such 
as inflammatory bowel disease and psoriatic arthritis in humans (Cătană et al. 2015, Suzuki et 
al. 2014). 
 
Recently it has been reported that women with unexplained repeated implantation failure have 
significantly higher expressions of IL23A, IL17, and IL6 in their uterine biopsies compared to 
healthy women (Amjadi et al. 2020). Such results are in agreement with our findings, which 
showed that the SNP mares showed a higher expression of IL23A higher than RP mares. It is 
assumed that IL23A can trigger the release of the proinflammatory IL6 cytokine, which is 
believed to be essential for the control of post-breeding inflammatory reactions in mares 




4.4 Lower expressed genes in susceptible mares that become pregnant compared to 
susceptible mares that did not become pregnant 
SP mares displayed lower expression of some genes compared to SNP mares, these DEGs are 
significantly enriched for cellular component organization and biogenesis (degradation of the 
extracellular matrix, focal adhesion), regulation of biological (negative regulation of 
proteolysis) and developmental processes (cell junction assembly). A disintegrin and 
metalloprotease with a thrombospondin motif5 (ADAMTS 5), Collagen type V alpha 2 
(COL5A2), Collagen type Ⅳ alpha 3 (COL4A3) and Fibronectin (FN1) genes were higher 
expressed in SNP mares than in SP mares and such genes are related to extracellular matrix 
(ECM) degradation, tissue adhesions and fibrosis. 
 
ECM is a non-cellular component found in all organs and tissues providing physical support to 
the cells. ECM is a highly dynamic structure that is frequently remodeled by enzymatic or non-
enzymatic means to maintain homeostasis of tissues (Järveläinen et al. 2009, Schmidt and 
Friedl 2010). Many proteases are implicated in the proteolytic degradation of ECM proteins, 
the most common of which are members of the matrix metalloproteinases (MMP), ADAMTS 
and tissue inhibitor of metalloproteinases (TIMPs) (Reiss and Saftig 2009, Egeblad et al. 2010). 
In the uterus, proteolytic degradation regulates the ECM proteins. Any imbalance of the ECM 
degradation process can lead to implantation abnormalities and infertility (Skinner et al. 1999). 
 
The family of ADAMTS genes consists of 19 proteases with a wide range of functions in 
different tissues, like ECM remodeling, angiogenesis, fibrosis and coagulation. Many functions 
are reported for ADAMTS proteases under various physiological and pathological conditions, 
such as implantation, embryogenesis, inflammation, tissue degradation and repair (Shiomi et 
al. 2010, Nandadasa et al. 2014). 
 
Our results demonstrated lower expression of ECM organizing genes ADAMTS 5, collagen 
COL4A3 and COL5A2 in SP mares compared to SNP mares. Similar results from bovine 
studies have shown that endometrial expressions of ECM-related genes (ADAMTS 5 and 
COL1A2, COL3A1, COL7A1 and COL3A3) are downregulated in cows with a high 
endometrial receptivity and healthy cows compared to cows with a low endometrial receptivity 
(Scolari et al. 2016). ADAMTS5 is also linked to men's infertility, as sperm counts, and motility 
has been reported to show a negative correlation with levels of ADAMTS5 protein in semen 
(Aydos et al. 2016). 
 
46  
Collagen is the key element of the ECM and plays a crucial role in wound healing. However, 
excessive synthesis of collagen contributes to organ fibrosis (Dupuy et al. 2019, Desogere et 
al. 2019). COL5A2 is known as a regulatory fibril-forming collagen, its expression is 
significantly up-regulated in conjunction with fibrosis in the renal epithelial cell lines and rat 
liver fibrosis (Zhang et al. 2015). 
Our results show high mRNA expression of COL5A2 and COL4A3 in the endometrium of 
SNP compared to SP mares. Recently, it has been shown that the expression of COL5A2 is up 
regulated and linked with the degree of intrauterine adhesions (Chen et al. 2020). In accordance 
with our results, an abundance of collagen genes including COL4A3 was upregulated in low-
fertility cow heifers in a study of Killeen et al. (2016). On the other hand, a lower expression 
of type IV collagen is observed in the decidua of spontaneously aborting women (Aplin 1996, 
Iwahashi et al. 1996). 
 
FBN1 and FN1 genes are encoded for extracellular matrix glycoproteins. FN1 plays a crucial 
role in cell adhesion, growth, migration, and differentiation, and is important for processes 
including wound healing and embryonic development (Pankov et al. 2002). A high expression 
fibronectin has been associated with many pathologies, including cancer and fibrosis (Williams 
et al. 2008). 
 
Our study shows that SNP mares expressed elevated levels of FN1. Similarly, the endometrial 
expression of FN1 has been reported to be significantly higher in non-pregnant compared to 
pregnant canine uteri (Graubner et al. 2018). FN1 is also associated with women's infertility. 
FN1 is reported to be the most up-regulated gene in women with uterine leiomyoma (Litovkin 
et al 2008). Moreover, the level of mRNA expression of the FN1 gene is higher in women with 
endometriosis compared to healthy women (Deraya et al. 2020). In one study of Bauersachs et 
al. (2005) mRNA expression of FN1 and COL5A2 was upregulated in the bovine uterus during 
the estrus. However, the authors of this study did not relate the expression of these genes to 
pregnancy results. 
 
Collagen IV and FN1 deposition outside the basement membrane is observed in the equine 
uterus in the case of glandular fibrosis (Walter et al. 2001). Hence, we believe that the SNP 
mares may develop a more distinct endometrial fibrosis as they expressed higher levels of 
ADAMTS 5, COL5A2, COL4A3 and FN1 than SP mare which may be an explanation for 
pregnancy failure in this mares. 
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4.5 Genes of higher expression in susceptible mares that become pregnant  compared to 
susceptible mares that did not become pregnant 
The present study identified some genes higher expressed in SP mares compared to SNP mares. 
These genes are associated with cellular response to growth factor stimulus, signaling, cell 
proliferation and developmental processes involved in reproduction. Fibroblast growth factor 
9 (FGF9), Growth differentiation factor 10 (GDF10), kinase insert domain receptor (KDR) and 
C-X-C motif chemokine ligand (CXCL) 16 genes were higher expressed in SP mares compared 
to SNP mares. These genes are related to uterine cell proliferation, differentiation, and 
angiogenesis. 
 
The FGF9 gene encodes for a protein belonging to the FGF family, which induce various 
cellular functions such as migration, proliferation and differentiation (Yun et al. 2010, Itoh et 
al. 2011). It affects a wide range of physiological and pathological processes, such as 
embryonic development, angiogenesis and tumorigenesis (Beenken and Mohammadi 2009). 
The biological function of FGFs is regulated through binding with transmembrane tyrosine 
kinase receptors. FGFR is encoded by four distinct genes (FGFR1–FGFR4) (Eswarakumar et 
al. 2005). FGF9 binds with high affinity to FGFR2 and FGFR3 (Ornitz et al. 1996). 
 
FGF9 functions as paracrine and/or autocrine mediators of epithelial-stromal interactions 
which trigger luminal epithelium proliferation in the uterus (Fujimoto et al. 1997, Filant et al. 
2014). In the uterus of fertile women, FGF9 is expressed at high levels, particularly during the 
late proliferative phase, which correlates with the rise of estradiol and the time of uterine 
endometrial proliferation (Tsai et al. 2002). Furthermore, FGF9 is reported to be a major 
element required to establish an optimal microenvironment for successful implantation and 
pregnancy in mares, women, mice and sows (Merkl et al. 2010, Tsai et al. 2002, Šućurović et 
al. 2017, Ostrup et al. 2010). 
 
The equine conceptus starts to secrete substantial amounts of estrogens on day 10 of pregnancy 
(Choi et al. 1997), which are expected to have many impacts on early pregnancy including 
stimulation of early conceptual migration, alterations in uterine tonicity and blood flow, and 
endometrial secretory activity, which is important for the nutrition of the preimplantation 
concept (Stout and Allen 2001). FGF9 is an important mediator of estrogen signaling in the 
equine uterus. It is reported to be upregulated during estrus and on day 12 of pregnancy in the 
normal equine endometrium (Gebhardt et al. 2012, Merkl et al. 2010). 
 
48  
 In addition, the mRNA expression of FGF9 is reported to be higher in the uterus of pregnant 
sows and women compared to the non-pregnant individuals (Ostrup et al. 2010, Tsai et al. 
2002). 
 
The GDF10 is another gene encodes for growth factor protein found to be higher expressed in 
SP relative to the SNP. GDFs are members of the transforming growth factor-b (TGF-b) 
superfamily that participate in many cellular functions and biological processes such as cell 
proliferation, differentiation and remodeling (Whitman 1998). 
 
Earlier research reported the role of GDF genes in the regulation of prenatal uterine 
development (Tong et al. 2004). The members of the GDF family have also been shown to play 
a critical role in the regulation of oocyte development (Gui and Joyce 2005). GDF10 mRNA 
expression is reported to be high in the pregnant endometrium of cattle (Mamo et al. 2012). 
Furthermore, it has been reported that the endometrium expresses elevated levels of GDF10 on 
day 16 of pregnancy in the mares (Klein 2015). 
 
In agreement with Klein (2015) and Gebhardt et al. (2012), our results showed higher 
expressions of FGF9 and GDF10 in SP mares compared to SNP mares. We believe that 
susceptible mares with high FGF9 and GDF10 profiles may become pregnant if the 
accumulated intrauterine fluid is properly handled within breeding. 
 
Vascular endothelial growth factor receptor 2 (VEGFR2) or kinase insert domain receptor 
(KDR) gene encodes for a tyrosine-protein that functions as a cell-surface receptor for vascular 
endothelial growth factor (VEGF) that plays an important role in the regulating of angiogenesis, 
vascular production, vascular permeability and embryonic hematopoiesis. Besides, it induces 
endothelial cells proliferation, survival, migration, and differentiation (Gerber et al. 1998, Jia 
et al. 2004). VEGF regulates normal uterine vascularity through its action on endothelial cells 
of blood vessels via two membrane receptors: VEGFR1 and KDR (Sağsöz and Saruhan, 2011). 
Signaling via KDR is suggested to be responsible for this VEGF activity rather than through 
VEGFR1 (Ferrara et al. 2003). VEGF ligand and its receptors are present in the endometrium's 
luminal epithelium, glandular epithelium, stroma, and blood vessels with variable expression 





Cyclic morphological changes in the endometrium are accompanied by a significant 
remodeling of the vasculature to create a receptive environment (Torry et al. 2007). Such 
vascular remodeling depends on hormonally regulated angiogenesis (Walter et al. 2010). 
Angiogenesis is a critical aspect of normal implantation/placentation at the early stages of 
pregnancy. Many studies have been focused on the existence of the signals responsible for 
triggering and regulating endometrial angiogenesis (Girling and Rogers 2009, Herve' et al. 
2006). They have investigated the levels of VEGF and its receptors in the pregnant and non-
pregnant uterus and found cycle-dependent expressions in rabbits (Das et al. 1997), pig 
(Winther et al. 1999), human (Moller et al. 2001), cows (Sağsöz and Saruhan, 2011) and sheep 
(Tremaine and Fouladi-Nashta 2018).  
 
The upregulation of KDR expression is associated with increased levels of estrogens and VEGF 
(Herve' et al. 2006). In addition, Rockwell et al. (2002) found that immunosuppression of 
VEGF decreased the estrogen-induced uterine edema and blocked implantation. 
 
In mares, the pattern of immunohistochemistry localization of KDR differs between pregnant 
and cyclic mares. KDR staining is low in the luminal endometrial cells of cyclic mares during 
estrus (Allen et al. 2007). KDR expression was highest in pregnant mares on day 21. This may 
indicate the role of the embryo-derived estrogens at the time of implantation, suggesting the 
involvement of VEGF and KDR pathways in stimulating the production of maternal and fetal 
vascular networks for the exchange of gases, nutrients and waste products during pregnancy 
(Silva et al. 2011). 
 
However, an earlier study of Allen et al. (2007) showed a low level of KDR expression in 
equine endometrium during estrus, our study demonstrated that SP mares have a higher mRNA 
expression of KDR than SNP mares during estrus, this discrepancy may be attributable to the 
use of different techniques for the assessment of KDR expression in the equine uterus as Allen 
et al. (2007) used immunohistochemistry to localize the KDR protein while we used 
transcriptomics to detect the KDR gene expression, we assume that the PBIE susceptible mares 
with high KDR profiles can become pregnant if the intrauterine fluid is controlled by using 
ecbolic drugs to remove fluid accumulations after AI. 
 
Chemokines are a special type of cytokines that are specifically recognized to have a role in 
leukocyte trafficking, CXCL16 is a member of the chemokine family, and CXC chemokine 
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receptor (CXCR6) is its main receptor (Matloubian et al. 2000). Emerging evidence has shown 
that CXCL16/CXCR6 is expressed at the maternal-fetal interface by cell types including 
trophoblast cells, decidual stromal cells, and decidual immune cells (e.g. monocytes and T 
cells). CXCL16 plays a crucial role in establishing a successful pregnancy via many molecular 
interactions at the maternal-fetal interface (Shi et al. 2019). 
 
In equine, the uterine mRNA expression of CXCL16 is reported to be at the highest level during 
the follicular phase of the estrous cycle, which affirms the assumption that the cytokine 
CXCL16 plays an important role in the uterine clearance after AI (Gebhardt et al. 2012).  
Cytokines are triggered by the entrance of sperm and microorganisms (Troedsson et al. 2001), 
which contribute to the influx of polymorphonuclear neutrophils into the uterine lumen 
(Troedsson 1999). 
 
The existence of an embryo in the uterus mediates the immunomodulatory activity of the 
uterus, which is further emphasized by the up-regulation of several chemokines (including 
CXCL16) necessary as regulators of maternal receptivity and embryo implantation (Sharkey 
1998, Tartakovsky and Ben-Yair 1991). In addition to promoting cell proliferation and the 
invasion of trophoblasts (Simon et al. 1998, Zheng et al. 2007), CXCL16 / CXCR6 chemokine 
receptor-axis is stated to be up-regulated in the pregnant canine uterus to induce proliferation 
and to modulate the immune system in preparation for implantation and placenta (Graubner et 
al. 2017). 
 
Human studies show that CXCL16 is impaired at the human maternal-fetal interface in patients 
with recurrent pregnancy loss (Huang et al. 2008, Fan et al. 2019). It is observed that CXCL16 
encourages the proliferation and autocrine invasiveness of primary-cultivated trophoblasts 
(Huang et al. 2006). In addition, CXCL16 is known to be an initiator of molecular crosstalk 
that stimulates the decidualization of endometrial cells, indicating that CXCL16/CXCR6 
chemokine plays a significant role in the development and progression of human placenta (Mei 
et al. 2019). 
 
The present study shows higher mRNA expression of CXCL16 in the SP mares uterus 





4.6 Limitations of the study 
Mares in the present study were classified into mares that did become pregnant or not based on 
the result of pregnancy checks after the artificial insemination using semen of different 
stallions. We cannot rule out the possibility of pregnancy being affected by the fertility of the 
individual stallions, however, we included only mares that were inseminated with the semen 
of fertile stallions. Furthermore, the hierarchical cluster analysis of the DEGs showed only 
partial separation of the different mare groups for both SNP-RP and SP-SNP comparisons. This 
could be due to some weakness in the classification of the mares. The animals and the breeding 
management of selected mares of the different groups of mares were similar, but not completely 
the same. In addition to the number of mares included in our study was relatively low. 
 
4.7 Conclusion 
In conclusion, the present study shows substantial differences in the uterine transcriptome 
profiles between susceptible mares that did not become pregnant in comparison to resistant 
mares that became pregnant in estrus even before the breeding challenge. We have identified a 
number of DEGs as possible molecular biomarkers for the susceptibility to PBIE, such 
transcripts of genes associated with steroid hormones metabolism, neutrophils chemotaxes, 
development, and maintenance of uterine inflammation. Furthermore, we have demonstrated 
that even among mares that tend to accumulate abnormal intrauterine fluids, there were 
significant differences in the uterine transcriptome profiles that may be related to the mare’s 
ability to become pregnant. The DEGs between susceptible mares that became pregnant or not 
were assumed to be useful indicators for the fertility of susceptible mares if they receive proper 
breeding management. These DEGs are related to ECM degradation, tissue adhesions fibrosis, 
uterine cell proliferation, differentiation, and angiogenesis. In order to verify our findings 
regarding the prediction of PBIE susceptibility and the overall fertility of broodmares, further 
studies are needed with a focus on the expression of specific genes in larger populations of 
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